Varicella-zoster virus and virus DNA in the blood and oropharynx of people with latent or active varicella-zoster virus infections

被引:30
|
作者
Levin, Myron J. [1 ]
机构
[1] Univ Colorado, Sch Med, Sect Pediat Infect Dis, Aurora, CO 80045 USA
关键词
Varicella-zoster virus; Viremia; DNAemia; Varicella; Herpes zoster; HERPES-SIMPLEX-VIRUS; POLYMERASE-CHAIN-REACTION; MONONUCLEAR-CELLS; VIRAL LOAD; VZV DNA; NONIMMUNOCOMPROMISED CHILDREN; IMMUNOCOMPROMISED PATIENTS; SUBCLINICAL REACTIVATION; POSTHERPETIC NEURALGIA; HEALTHY-INDIVIDUALS;
D O I
10.1016/j.jcv.2014.09.012
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Varicella-zoster virus (VZV) can be detected in the blood from approximately 5 days before to 4 days after varicella. VZV DNA, primarily in T-lymphocytes, is detected as early as 8-10 days prior to rash and can persist for a week. The duration and magnitude of VZV DNAemia correlates with immune status and the efficacy of antiviral therapy. VZV DNA is also readily detected in the oropharynx just prior to rash and for 1-2 weeks thereafter. Detection of VZV DNA in blood and saliva has been useful for diagnosis and prognosis in atypical cases of varicella. Herpes zoster (HZ) is also characterized by VZV DNAemia at onset and for many weeks thereafter, and VZV DNA is present in the oropharynx shortly after HZ onset. Detection of VZV DNA in blood and saliva facilitates the diagnosis of zoster sine herpete and other atypical manifestations of VZV reactivation, such as neurologic syndromes when cerebrospinal fluid is not available, Bell's palsy, and atypical pain syndromes. VZV DNA is sometimes present in the blood and saliva of asymptomatic individuals. In total these observations extend understanding of the pathophysiology and epidemiology of VZV, and increasingly contribute to the clinical management of VZV infections. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:487 / 495
页数:9
相关论文
共 50 条
  • [1] Varicella-zoster virus infections
    Lilie, HM
    Wassilew, SW
    HAUTARZT, 2004, 55 (09): : 831 - +
  • [2] Varicella-zoster virus Infections in pregnancy
    Sauerbrei, A
    INTERVIROLOGY, 1998, 41 (4-5) : 191 - 196
  • [3] DETECTION OF VARICELLA-ZOSTER VIRUS-DNA IN BLOOD OF CHILDREN WITH VARICELLA
    OZAKI, T
    KAJITA, Y
    ASANO, Y
    AONO, T
    YAMANISHI, K
    JOURNAL OF MEDICAL VIROLOGY, 1994, 44 (03) : 263 - 265
  • [4] Emerging drugs for varicella-zoster virus infections
    Andrei, Graciela
    Snoeck, Robert
    EXPERT OPINION ON EMERGING DRUGS, 2011, 16 (03) : 507 - 535
  • [5] Seroprevalence of Varicella-Zoster Virus in Korea
    Choi, Won Suk
    Noh, Ji Yun
    Huh, Joong Yeon
    Jo, Yu Mi
    Lee, Jacob
    Song, Joon Young
    Kim, Woo Joo
    Cheong, Hee Jin
    JOURNAL OF MEDICAL VIROLOGY, 2010, 82 (12) : 2123 - 2126
  • [6] Varicella-zoster virus eye disease
    Liesegang, TJ
    CORNEA, 1999, 18 (05) : 511 - 531
  • [7] The varicella-zoster virus and multiple sclerosis
    Ross, RT
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (07) : 533 - 535
  • [8] Persistence of varicella-zoster virus viraemia in patients with herpes zoster
    Quinlivan, M. L.
    Ayres, K. L.
    Kelly, P. J.
    Parker, S. P.
    Scott, F. T.
    Johnson, R. W.
    Maple, C.
    Breuer, J.
    JOURNAL OF CLINICAL VIROLOGY, 2011, 50 (02) : 130 - 135
  • [9] CHEMOTHERAPY OF VARICELLA-ZOSTER VIRUS-INFECTIONS
    SNOECK, R
    ANDREI, G
    DECLERCQ, E
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1994, 4 (03) : 211 - 226
  • [10] Varicella-zoster virus and pregnancy
    Charlier, Caroline
    Le Mercier, Delphine
    Salomon, Laurent J.
    Ville, Yves
    Kermorvant-Duchemin, Elsa
    Frange, Pierre
    Postaire, Martine
    Lortholary, Olivier
    Lecuit, Marc
    Leruez-Ville, Marianne
    PRESSE MEDICALE, 2014, 43 (06): : 665 - 675